[
    "{\"step_by_step_thinking\": \"The patient is presenting with an exacerbation of his chronic obstructive pulmonary disease (COPD). The goal of treatment in such cases is to reduce symptoms and prevent future exacerbations. Oral prednisone is often used in the acute management of COPD exacerbations, but it does not reduce the risk of future exacerbations. Supplemental oxygen is used in patients with severe COPD and resting hypoxemia, but it does not reduce the risk of future exacerbations. Montelukast is a leukotriene receptor antagonist used in the treatment of asthma, but it has not been shown to reduce exacerbations in COPD. Nebulized N-acetylcysteine has been shown to reduce the risk of exacerbations in COPD patients.\", \"answer_choice\": \"D. Nebulized N-acetylcysteine\"}"
]